Recognizing and Managing Iron Deficiency Anemia in Gastrointestinal Disorders

Recognizing and Managing Iron Deficiency Anemia in Gastrointestinal Disorders is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Dec 21, 2018 - Dec 21, 2019.

Accreditation:
CME
Purdue University designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 credit.
PAs should only claim credit commensurate with the extent of their participation.

CNE
This continuing nursing education activity awards 1.0 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

CPE
This knowledge-based activity (JA0006201-9999-18-244-H01-P) is approved for 1.0 contact hour (0.01 CEUs) of continuing pharmacy education.

Target Audience:
This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with iron deficiency anemia (IDA) with Inflammatory Bowel Disease (IBD).

Overview:
While epidemiologic data indicate that iron deficiency anemia (IDA) occurs in up to 76% of patients with IBD, many of its symptoms can be undetected or attributed to the IBD process, thereby allowing iron deficiency to be overlooked and untreated.
Although iron replacement therapy remains the cornerstone of managing iron deficiency, a broad range of oral and intravenous iron preparations are available, some of which have been specifically studied in IBD patients. Appropriate use of these agents requires understanding the considerable differences among these agents with regard to formulation, dosing, safety, and efficacy.
In this webcast from the Recognizing & Managing Iron Deficiency Anemia in Inflammatory Bowel Disease symposium held during the 2018 Advances in Inflammatory Bowel Diseases on December 15, 2018, Drs. Stephen B. Hanauer, Gary R. Lichtenstein and Edward V. Loftus review the latest data and explore current approaches to managing IDA in IBD.

Objectives:
Upon successful completion of this educational activity, participants should be better able to:
• Describe the prevalence of IDA in patients with IBD
• Proactively identify patients with IDA
• Describe the pathophysiologic processes that underlie IDA in patients with IBD
• Differentiate among various oral and IV iron formulations and incorporate them effectively into clinical practice